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Background:  Implantable cardioverter defibrillator (ICD) is the standard to prevent sudden cardiac death in patients with heart failure (HF) and 
ejection fraction (EF) ≤ 35%. The relationship between obesity and HF is not clear; studies have reported reduced mortality rate in patients with 
increased body mass index (BMI). This link has not been established for patients who received an ICD.
Methods:  Of patients who received ICD in our institution from January 2007 to June 2009, 1,342 patients had congestive HF with NYHA class 
II and III and EF ≤ 35%. Group A, BMI < 30 (819 patients), and Group B, BMI ≥ 30 (523 patients), were followed for a median of 503 days. We 
compared adverse reactions, cardiac events, hospital readmission, and mortality.
Results:  Group A was older (69.9 ± 12.4 vs. 64 ± 12.2 years, p<0.001) and had more males (76.6% vs. 71.3% p=0.032). Group B had more 
diabetes mellitus (47% vs. 29.9% p<0.001) and hypertension (81.8% vs. 73% p<0.001) and less coronary artery disease (65.6% vs. 70.8% 
p=0.044). Group A had longer hospital stay (1.74 ± 2.5 vs. 1.48 ± 1.8 days, p<0.001), more post-implant acute myocardial infarction (2% vs. 0%, 
p<0.001) and more post-implant arrhythmia (4.2% vs. 0%, p<0.001). By Kaplan-Meier and multivariate analysis, Group B had a significantly higher 
survival rate post-implant than Group A (15.3% vs. 8.8%, p<0.001).
Conclusions:  Low BMI is a predictor of worse outcome in ICD recipients with heart failure, and is associated with a higher mortality rate and an 
increase in cardiac events.
 
